Herbas VPB

Print
EN | LT
LT - 2-Amino-N-(piperidin-1-il-piridin-3-il)pirazolo[1,5alfa]pirimidin-3-karboksamidas, kaip ATR kinazės inhibitorius
EN - 2-AMINO-N-(PIPERIDIN-1-YL-PYRIDIN-3-YL) PYRAZOLO[1,5ALPHA]PYRIMIDINE-3-CARBOXAMID AS INHIBITOR OF ATR KINASE

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 487/04 (2006.01)
A61K 31/495 (2006.01)
A61P 35/00 (2006.01)
C07D 453/02 (2006.01)
C07D 471/08 (2006.01)
C07D 491/107 (2006.01)
C07D 498/04 (2006.01)
C07D 498/10 (2006.01)
European patent
(11) Number of the document 3486245
(13) Kind of document T
(96) European patent application number 18212042.8
Date of filing the European patent application 2013-12-06
(97) Date of publication of the European application 2019-05-22
(45) Date of publication and mention of the grant of the patent 2021-04-28
(46) Date of publication of the claims translation 2021-08-25
Priority applications
(30) Number Date Country code
201261734726 P 2012-12-07 US
201361787568 P 2013-03-15 US
201361868132 P 2013-08-21 US
Inventors
(72)
AHMAD, Nadia, GB
BOYALL, Dean, GB
CHARRIER, Jean-Damien, GB
DAVIS, Chris, GB
DAVIS, Rebecca, GB
DURRANT, Steven, GB
ETXEBARRIA I JARDI, Gorka, GB
FRAYSSE, Damien, GB
JIMENEZ, Juan-Miguel, GB
KAY, David, GB
KNEGTEL, Ronald, GB
MIDDELTON, Donald, GB
ODONNELL, Michael, GB
PANESAR, Maninder, GB
PIERARD, Francoise, GB
PINDER, Joanne, GB
SHAW, David, GB
STORCK, Pierre-Henri, GB
STUDLEY, John, GB
TWIN, Heather, GB
Grantee
(73) Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA 02210, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) 2-Amino-N-(piperidin-1-il-piridin-3-il)pirazolo[1,5alfa]pirimidin-3-karboksamidas, kaip ATR kinazės inhibitorius
  2-AMINO-N-(PIPERIDIN-1-YL-PYRIDIN-3-YL) PYRAZOLO[1,5ALPHA]PYRIMIDINE-3-CARBOXAMID AS INHIBITOR OF ATR KINASE
Last renewal fee
Payment date Validity (years) Amount
2025-11-18 13 289.00 EUR
Next renewal fee
2026-12-06